Order Article Reprints

Alamer AA, Alsaleh NB, Aodah AH, Alshehri AA, Almughem FA, Alqahtani SH, Alfassam HA, Tawfik EA. Development of Imeglimin Electrospun Nanofibers as a Potential Buccal Antidiabetic Therapeutic Approach. Pharmaceutics. 2023; 15(4):1208. https://doi.org/10.3390/pharmaceutics15041208

Alamer, Ali A., Nasser B. Alsaleh, Alhassan H. Aodah, Abdullah A. Alshehri, Fahad A. Almughem, Sarah H. Alqahtani, Haya A. Alfassam, and Essam A. Tawfik. 2023. "Development of Imeglimin Electrospun Nanofibers as a Potential Buccal Antidiabetic Therapeutic Approach" Pharmaceutics 15, no. 4: 1208. https://doi.org/10.3390/pharmaceutics15041208

Alamer, A. A., Alsaleh, N. B., Aodah, A. H., Alshehri, A. A., Almughem, F. A., Alqahtani, S. H., Alfassam, H. A., & Tawfik, E. A. (2023). Development of Imeglimin Electrospun Nanofibers as a Potential Buccal Antidiabetic Therapeutic Approach. Pharmaceutics, 15(4), 1208. https://doi.org/10.3390/pharmaceutics15041208